Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

THE cellular prion protein (PrP c ) is a sialoglycoprotein of M r 33–35K that is expressed
predominantly in neurons 1–3 . In transmissible and genetic neurodegenerative disorders such …

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are mammalian
neurodegenerative disorders characterized by a posttranslational conversion and brain …

Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …

It has been recognized that molecular classifications will form the basis for neuropathological
diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's …

The tau gene has been found to be the locus of dementia with rigidity linked to chromosome
17. Exonic and intronic mutations have been described in a number of families. Here we …

β-Amyloid precursor protein (APP) mutations cause familial Alzheimer's disease with nearly
complete penetrance. We found an APP mutation [alanine-673→valine-673 (A673V)] that …

Pathological accumulation of abnormally phosphorylated tau protein in astrocytes is a
frequent, but poorly characterized feature of the aging brain. Its etiology is uncertain, but its …

Human prion diseases can be sporadic, inherited, or acquired by infection. Distinct clinical
and pathological characteristics separate sporadic diseases into three phenotypes: …

Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …